Best treatments for primary ovarian insufficiency

Understanding primary ovarian insufficiency

Primary ovarian insufficiency (POI) is the clinical name for ovaries losing normal function before age 40. MedlinePlus (NLM) puts it plainly: "Primary ovarian insufficiency (POI) happens when your ovaries stop working normally before you are 40." The label is not a synonym for early menopause, and the distinction changes what people do next. StatPearls (NCBI Bookshelf) explains that POI differs from menopause because of the remaining variability of ovarian function and surviving primordial follicles, whereas menopause occurs once those follicles are exhausted. MedlinePlus adds that with POI "some women still have occasional periods. They may even get pregnant." So POI is not a diagnosis of sterility: the 2024 evidence-based POI guideline (ESHRE, endorsed by ASRM, CRE-WHiRL and IMS) says women with non-surgical POI should be advised to use contraception if they wish to avoid pregnancy. The usual first sign, per MedlinePlus, is irregular or missed periods — not hot flashes. Diagnosis rests on menstrual history plus hormone blood tests; the 2024 guideline defines POI as disordered menstrual cycles for at least 4 months together with an elevated FSH concentration above 25 IU/L. NICHD (NIH) describes the blood work as repeated testing, and says that if the FSH level in both tests is as high as it is in women who have gone through menopause, then POI is likely. MedlinePlus notes that in about 90% of cases the exact cause is unknown. This is general information, not medical advice; decisions about testing or treatment belong with your own clinician.

Frequently asked

What treats primary ovarian insufficiency?

Our catalog lists 14 products that may treat primary ovarian insufficiency, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is elestrin.

What is the best-rated treatment for primary ovarian insufficiency?

By our independent recall-safety rating — not an efficacy measure — elestrin ranks highest among the products we list for primary ovarian insufficiency. Always consult a professional.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat primary ovarian insufficiency?

Treatments for primary ovarian insufficiency span FDA drug classes including estrogen. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.